Cargando…

Chloroquine and Hydroxychloroquine, as Proteasome Inhibitors, Upregulate the Expression and Activity of Organic Anion Transporter 3

Organic anion transporter 3 (OAT3), at the basolateral membrane of kidney proximal tubule cells, facilitates the elimination of numerous widely used drugs. Earlier investigation from our laboratory revealed that ubiquitin conjugation to OAT3 leads to OAT3 internalization from the cell surface, follo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Zhengxuan, You, Guofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303059/ https://www.ncbi.nlm.nih.gov/pubmed/37376173 http://dx.doi.org/10.3390/pharmaceutics15061725

Ejemplares similares

Oral Proteasomal Inhibitors Ixazomib, Oprozomib, and Delanzomib Upregulate the Function of Organic Anion Transporter 3 (OAT3): Implications in OAT3-Mediated Drug-Drug Interactions
por: Fan, Yunzhou, et al.
Publicado: (2021)

Protein kinase C regulates organic anion transporter 1 through phosphorylating ubiquitin ligase Nedd4–2
por: Yu, Zhou, et al.
Publicado: (2021)

AG490, a JAK2-specific inhibitor, downregulates the expression and activity of organic anion transporter-3
por: Zhang, Jinghui, et al.
Publicado: (2018)

Pharmacology of Chloroquine and Hydroxychloroquine
por: Browning, David J.
Publicado: (2014)

Chloroquine/hydroxychloroquine overdose
por: McKeever, Rita
Publicado: (2020)

Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
por: Bahadoram, Mohammad, et al.
Publicado: (2021)

Chloroquine and hydroxychloroquine for cancer therapy
por: Manic, Gwenola, et al.
Publicado: (2014)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Reported ADRs with chloroquine or hydroxychloroquine
Publicado: (2021)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
por: Stevens, David M., et al.
Publicado: (2020)

Interaction of Anticancer Drugs with Human Organic Anion Transporter hOAT4
por: Liu, Chenchang, et al.
Publicado: (2019)

Hydroxychloroquine- and chloroquine-related cardiovascular events
Publicado: (2020)

Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

Insulin-like growth factor 1 modulates the phosphorylation, expression, and activity of organic anion transporter 3 through protein kinase A signaling pathway
por: Zhang, Jinghui, et al.
Publicado: (2020)

Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner
por: Alam, Khondoker, et al.
Publicado: (2017)

Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine
por: Gies, Vincent, et al.
Publicado: (2020)

Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management
por: Lebin, Jacob A., et al.
Publicado: (2020)

Risks of chloroquine or hydroxychloroquine use for COVID-19
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
por: Ho, Tzu-Chuan, et al.
Publicado: (2021)

The Ototoxicity of Chloroquine and Hydroxychloroquine: A Systematic Review
por: Fernandes, Carolina Pereira, et al.
Publicado: (2022)

Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19
por: Singh, Bhagteshwar, et al.
Publicado: (2021)

Evidence for Chloroquine/Hydroxychloroquine in the Treatment of COVID-19
por: Shetty, Rajesh M, et al.
Publicado: (2021)

Cardiotoxicity of chloroquine and hydroxychloroquine through mitochondrial pathway
por: Seydi, Enayatollah, et al.
Publicado: (2023)

Chloroquine and Hydroxychloroquine in the Treatment of Dry Eye Disease
por: Prinz, Julia, et al.
Publicado: (2023)

Quantitative Fundus Autofluorescence in Systemic Chloroquine/Hydroxychloroquine Therapy
por: Reichel, Clara, et al.
Publicado: (2020)

Chloroquine or Hydroxychloroquine for COVID‐19: Is Cardiotoxicity a Concern?
por: Kamp, Timothy J., et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
por: Carafoli, Ernesto
Publicado: (2021)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
por: Colson, Philippe, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine increase risk of death in COVID-19
Publicado: (2020)

Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment Outcomes
por: Naddaf, Elie, et al.
Publicado: (2021)

PRAC review confirms chloroquine- and hydroxychloroquine-related AEs
Publicado: (2020)

Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter
por: Gupta, Anunay, et al.
Publicado: (2020)

Overview of organic anion transporters and organic anion transporter polypeptides and their roles in the liver
por: Li, Ting-Ting, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3meedhbepno4depfu0asbnaqf8